Market News & Trends
Enable Injections Completes Cincinnati Manufacturing Facility for On-Body Delivery Systems
Enable Injections Inc. opened its new Cincinnati manufacturing facility this month, the company announced at the BIO meeting in San Francisco. Enable Injections’ advanced On…
Cobra Biologics & Touchlight Collaborate on Production of Next-Generation DNA Constructs
Cobra Biologics Ltd and Touchlight are collaborating on a project to optimize the manufacture of Adeno-Associated Virus (AAV) vectors used in the delivery of gene…
BioDuro Launches as Unique Contract Research & Drug Manufacturing Organization
BioDuro, LLC recently announced the formal launch of the BioDuro organization, having merged with Formex to become an end-to-end solution provider for integrated drug discovery…
Averica & Dalton Announce Analytical Chemistry Services Agreement
Averica Discovery Services Inc. and Dalton Pharma Services recently announced a preferred provider agreement involving advanced analytical services. The agreement leverages the strengths of both…
PhRMA Release: Decade of Breakthroughs In Cancer
The pace of science is yielding remarkable innovation for cancer patients as we learn more about the underlying factors driving the spread and growth of…
Agile Sciences Creates a Powerful New Weapon in the Fight Against Antibiotic Resistance
Agile Sciences in Raleigh, NC, has developed a potentially powerful, effective, and affordable means to stem the tide of antibiotic resistance. Results show that their…
Phillips-Medsize Acquires Medicom
Phillips-Medisize Corporation recently announced that it has acquired Medicom Innovation Partner, a leading provider of device strategy, product design, and development services with particular focus…
Genisphere Signs Collaborative Research, Option to License Agreement With MedImmune
Genisphere LLC recently announced it has executed a collaborative research and option to license agreement with MedImmune, the global biologics research and development arm of…
Noxilizer Announces FDA 510(k) Clearance of a Medical Device Sterilized Using a NO2 Process
Noxilizer, Inc. recently announced a 510(k) clearance from the US FDA for a medical device terminally sterilized using Noxilizer’s nitrogen dioxide sterilization process. "Receiving a…
Oncternal Therapeutics Merges With Tokalas to Form Clinical-Stage Biotechnology Company
Oncternal Therapeutics, Inc. and Tokalas, Inc., recently announced the two companies have completed a merger to create a new world-class clinical-stage oncology company with two…